These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 1582820

  • 1. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.
    Hanna SL, Parham DM, Fairclough DL, Meyer WH, Le AH, Fletcher BD.
    Invest Radiol; 1992 May; 27(5):367-73. PubMed ID: 1582820
    [Abstract] [Full Text] [Related]

  • 2. Automated pixel-by-pixel mapping of dynamic contrast-enhanced MR images for evaluation of osteosarcoma response to chemotherapy: preliminary results.
    Hanna SL, Reddick WE, Parham DM, Gronemeyer SA, Taylor JS, Fletcher BD.
    J Magn Reson Imaging; 1993 May; 3(6):849-53. PubMed ID: 8280973
    [Abstract] [Full Text] [Related]

  • 3. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
    de Baere T, Vanel D, Shapeero LG, Charpentier A, Terrier P, di Paola M.
    Radiology; 1992 Nov; 185(2):587-92. PubMed ID: 1410378
    [Abstract] [Full Text] [Related]

  • 4. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, Köhler G, Ilyasov K, Langer M.
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
    van der Woude HJ, Bloem JL, Verstraete KL, Taminiau AH, Nooy MA, Hogendoorn PC.
    AJR Am J Roentgenol; 1995 Sep; 165(3):593-8. PubMed ID: 7645476
    [Abstract] [Full Text] [Related]

  • 7. Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy.
    Reddick WE, Bhargava R, Taylor JS, Meyer WH, Fletcher BD.
    J Magn Reson Imaging; 1995 Sep; 5(6):689-94. PubMed ID: 8748487
    [Abstract] [Full Text] [Related]

  • 8. Dynamic contrast enhanced magnetic resonance imaging subtraction in evaluating osteosarcoma response to chemotherapy.
    Torricelli P, Montanari N, Spina V, Manfrini M, Bertoni F, Saguatti G, Romagnoli R.
    Radiol Med; 2001 Mar; 101(3):145-51. PubMed ID: 11402952
    [Abstract] [Full Text] [Related]

  • 9. [High dosage Gd-DPTA-BMA (Gadodiamid) administration in diagnosis and therapeutic monitoring of malignant bone tumors].
    Häussler MD, Rummeny EJ, Raufhake C, Blasius S, Lindner N, Daldrup HE, Reimer P, Peters PE.
    Radiologe; 1996 Feb; 36(2):148-52. PubMed ID: 8867432
    [Abstract] [Full Text] [Related]

  • 10. Gadolinium-DTPA enhanced magnetic resonance imaging of bone and soft tissue sarcomas in comparison with pathological findings.
    Ozaki T, Inoue H, Taguchi K, Sugihara S.
    Acta Med Okayama; 1992 Dec; 46(6):471-7. PubMed ID: 1485542
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The potential of MRI in preoperative evaluation of chemotherapy-induced necrosis in osteosarcoma and Ewing's sarcoma.
    Maas R, Winkler K, Delling G, Heise U.
    Chir Organi Mov; 1990 Dec; 75(1 Suppl):41-4. PubMed ID: 2249554
    [No Abstract] [Full Text] [Related]

  • 13. Musculoskeletal neoplasms: static and dynamic Gd-DTPA--enhanced MR imaging.
    Erlemann R, Reiser MF, Peters PE, Vasallo P, Nommensen B, Kusnierz-Glaz CR, Ritter J, Roessner A.
    Radiology; 1989 Jun; 171(3):767-73. PubMed ID: 2717749
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Dynamic MR tomography in the diagnosis of inflammatory and tumorous space-occupying lesions of the musculoskeletal system].
    Erlemann R, Sciuk J, Wuisman P, Bene D, Edel G, Ritter J, Peters PE.
    Rofo; 1992 Apr; 156(4):353-9. PubMed ID: 1571517
    [Abstract] [Full Text] [Related]

  • 16. Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy.
    Bonnerot V, Charpentier A, Frouin F, Kalifa C, Vanel D, Di Paola R.
    Invest Radiol; 1992 Oct; 27(10):847-55. PubMed ID: 1399442
    [Abstract] [Full Text] [Related]

  • 17. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences].
    Venz S, Hosten N, Ilg J, Mäurer J, Podrabsky P, Fedel M, Ebert T, Nagel R.
    Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas.
    Uhl M, Saueressig U, Koehler G, Kontny U, Niemeyer C, Reichardt W, Ilyasof K, Bley T, Langer M.
    Pediatr Radiol; 2006 Dec; 36(12):1306-11. PubMed ID: 17031633
    [Abstract] [Full Text] [Related]

  • 19. Magnetic resonance imaging of disseminated bone marrow disease in patients treated for malignancy.
    Hanna SL, Fletcher BD, Fairclough DL, Jenkins JH, Le AH.
    Skeletal Radiol; 1991 Dec; 20(2):79-84. PubMed ID: 2020867
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.